Insulin Action in Individuals With Type 2 Diabetes by Natural Fatty Acids or the Medication Pioglitazone
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the changes in insulin (a hormone produced in the
body by the pancreas that regulates the amount of sugar in the blood) action and adiponectin
(a protein hormone which regulates sugar levels and fatty acid breakdown) levels after giving
individuals with type 2 diabetes a medication, pioglitazone, for three weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University